Chen, X., Zhou, C., Zeng, L., Geng, Y., Liu, Y. (2026). First-in-human phase I, open-label, multicenter study of HJ-004, a novel EGFR-PROTAC degrader, in patients with advanced EGFR -mutated non–small cell lung cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps8678